NCT05171595View on ClinicalTrials.gov

Real Time ST-segment Deviation Detection in High-risk Patients Detected by Wireless Single-lead ECG

CompletedOBSERVATIONAL
Enrollment

698

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

June 9, 2020

Study Completion Date

June 9, 2020

Conditions
Myocardial Injury
Interventions
DEVICE

Lifetouch single-lead ECG monitoring

The continuous wireless monitoring is a single-lead ECG patch (Isansys Life Touch patch) which consists of two ECG electrodes placed on the left side of the patients' thorax. The patch measures respiratory rate (RR), heart rate (HR), heart rate variability (HRV) and electrocardiogram (ECG)s.

DIAGNOSTIC_TEST

high-sensitive TnT measurements

Another monitoring device in the study was the plasma concentration of high-sensitive cardiac troponin T (hsTnT).

Trial Locations (1)

2100

Rigshospitalet, Department of Anesthesiology, Centre for Cancer and Organ Diseases, University of Copenhagen, Blegdamsvej 9, 2200 Copenhagen, Denmark, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT05171595 - Real Time ST-segment Deviation Detection in High-risk Patients Detected by Wireless Single-lead ECG | Biotech Hunter | Biotech Hunter